Company Profile
Nerre Therapeutics Ltd
07916206•Private Limited With Share Capital
Get Full Access
19/01/2012
14 years
6
13
72110
not scored
Company Overview
Registration, classification & business activity
Nerre Therapeutics Ltd (07916206) is a private limited with share capital incorporated on 19/01/2012 (14 years old) and registered in cambridge, CB12LA. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Nerre therapeutics is developing orvepitant, a neurokinin (nk)-1 receptor antagonist, as a first in class, once daily breakthrough treatment for cough hypersensitivity disorders. having demonstrated proof of efficacy in patients with refractory or unexplained cough, nerre will now continue developme...
Financial Overview
£2.47M
£25.80M
£-23.33M
£5.81M
£2.23M
Key Metrics
13
Employees
6
Directors
5
Shareholders
Board of Directors
Import / Export
Risk Assessment
not scored
International Score
Future Factor
emerging
Performance Rating